Clinical Trial Update: Open-label Safety Extension Study Assessing Safety and Tolerability of LAI in Patients Who Participated in Study INS-212 [Phase 3]

View source ↗

Summary

Open-label safety extension study assessing safety and tolerability of a long-acting formulation in patients who participated in the Phase 3 INS-212 trial for N…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycobacterium Avium Complex Lung Infection
• Ntm Lung Infection Due to Mac

Drugs mentioned

• LAI

Snippet

Sponsor: Insmed Incorporated | Conditions: NTM Lung Infection Due to MAC | Phase 3 | Status: COMPLETED | Results posted: 2019-11-19